Paper370597
Serratia marcescens: historical perspective and clinical review.
Yu VL. N Engl J Med, 1979. Cited by 244 papers, by iCite.
Cite this record
ConductScience Library. Serratia marcescens: historical perspective and clinical review. Papers, record 370597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/370597
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enterobacteriaceae Infections | Major topic |
| Serratia marcescens | Major topic |
| Aerosols | |
| Anti-Bacterial Agents | |
| Biological Warfare | |
| Child | |
| Cross Infection | |
| Drug Contamination | |
| Endocarditis, Bacterial | |
| History, Ancient | |
| History, Medieval | |
| History, Modern 1601- | |
| Humans | |
| Injections, Intravenous | |
| Microbiology | |
| Sepsis | |
| Substance-Related Disorders | |
| United States |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42878461 | A PhoP-regulated type II secretion system drives bacterial competition in Serratia marcescens. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42878461 | PubMed |
| 40718176 | Serratia marcescens as an Uncommon Cause of Infection Following Craniectomy: A Case Report and Literature Review. | Cureus | 2025 | https://conductscience.org/library/papers/40718176 | PubMed |
| 39816409 | An Antimicrobial Treatment Assessment of Serratia marcescens Bacteremia and Endocarditis. | Front Antibiot | 2022 | https://conductscience.org/library/papers/39816409 | PubMed |
| 38455744 | Recurrent Serratia marcescens osteomyelitis eight years after a contaminated open fracture: a case report and review of the literature. | Transl Pediatr | 2024 | https://conductscience.org/library/papers/38455744 | PubMed |
| 36536034 | New insights into the antibacterial mode of action of quercetin against uropathogen Serratia marcescens in-vivo and in-vitro. | Sci Rep | 2022 | https://conductscience.org/library/papers/36536034 | PubMed |
| 34694901 | The Diguanylate Cyclase YfiN of Pseudomonas aeruginosa Regulates Biofilm Maintenance in Response to Peroxide. | J Bacteriol | 2022 | https://conductscience.org/library/papers/34694901 | PubMed |
| 34491801 | A Genome-Scale Antibiotic Screen in Serratia marcescens Identifies YdgH as a Conserved Modifier of Cephalosporin and Detergent Susceptibility. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34491801 | PubMed |
| 34363530 | Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens. | Eur J Clin Microbiol Infect Dis | 2021 | https://conductscience.org/library/papers/34363530 | PubMed |
| 33996466 | Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam. | IDCases | 2021 | https://conductscience.org/library/papers/33996466 | PubMed |
| 33927048 | Serratia marcescens RamA Expression Is under PhoP-Dependent Control and Modulates Lipid A-Related Gene Transcription and Antibiotic Resistance Phenotypes. | J Bacteriol | 2021 | https://conductscience.org/library/papers/33927048 | PubMed |
| 33742033 | Characterisation of a tripartite α-pore forming toxin from Serratia marcescens. | Sci Rep | 2021 | https://conductscience.org/library/papers/33742033 | PubMed |
| 33153999 | Complete Genome Sequence of Serratia marcescens FY, Isolated from Drosophila melanogaster. | Microbiol Resour Announc | 2020 | https://conductscience.org/library/papers/33153999 | PubMed |
| 32983706 | Serratia marcescens Tricuspid Valve Vegetation and Successful Use of the AngioVac® System. | Cureus | 2020 | https://conductscience.org/library/papers/32983706 | PubMed |
| 32775082 | A Complicated Case of Vertebral Osteomyelitis by Serratia Marcescens. | Cureus | 2020 | https://conductscience.org/library/papers/32775082 | PubMed |
| 31956419 | Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology. | New Microbes New Infect | 2020 | https://conductscience.org/library/papers/31956419 | PubMed |
| 30196662 | Prospective Multicenter Surveillance Study of Surgical Site Infection after Intracranial Procedures in Korea : A Preliminary Study. | J Korean Neurosurg Soc | 2018 | https://conductscience.org/library/papers/30196662 | PubMed |
| 27682115 | Carbon-Starvation Induces Cross-Resistance to Thermal, Acid, and Oxidative Stress in Serratia marcescens. | Microorganisms | 2015 | https://conductscience.org/library/papers/27682115 | PubMed |
| 27346925 | Marvelous but Morbid: Infective endocarditis due to Serratia marcescens. | Infect Dis Clin Pract (Baltim Md) | 2016 | https://conductscience.org/library/papers/27346925 | PubMed |
| 27021420 | Is there a terrible issue with bacterial resistance: pro-con. | Clin Microbiol Infect | 2016 | https://conductscience.org/library/papers/27021420 | PubMed |
| 26621903 | Serratia marcescens osteomyelitis in Cushing's disease. | BMJ Case Rep | 2015 | https://conductscience.org/library/papers/26621903 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/370597
GET https://conductscience.org/api/papers/v1/370597/cited_by?page=2